Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Blood (2019) 134 (Supplement_1): 1321.

https://doi.org/10.1182/blood-2019-128568

Published: 2019

Journal Articles

Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

Juan Eduardo Megías-Vericat, PharmD, Montesinos Pau, MD PhD, María José Herrero, PhD, Federico Moscardó, MD PhD, Virginia Bosó, PharmD, David Martínez-Cuadrón, MD PhD, Luis Rojas, MD, Rebeca Rodríguez-Veiga, MD, David Hervás, Blanca Boluda, MD, Luis Sendra, PhD, Jaime Sanz, MD PhD, Antonio Miguel, PhD, Jose Cervera, MD PhD, José Luis Poveda, PhD, Salvador F Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2016) 128 (22): 5130.

https://doi.org/10.1182/blood.V128.22.5130.5130

Published: 2016

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, María José Herrero, PhD, Federico Moscardó, Virginia Bosó, PharmD, David Martínez-Cuadrón, MD, Luis Rojas, MD, Rebeca Rodríguez-Veiga, MD, Blanca Boluda, MD, Jesús Martínez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, MD, Aima Lancharro, MD, Jose Cervera, MD, David Hervás, José Luis Poveda, PhD, Salvador F Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2015) 126 (23): 4842.

https://doi.org/10.1182/blood.V126.23.4842.4842

Published: 2015

Journal Articles

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Blood (2015) 126 (23): 4845.

https://doi.org/10.1182/blood.V126.23.4845.4845

Published: 2015

Journal Articles

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Pilar Hernandez, PhD, Pau Montesinos, MD, Josefina Serrano, MD, Pilar Herrera, MD, Juan Pedro Bergua, MD, Mercedes Colorado, MD, Bernando J Gonzalez, MD, Cristina Gomez, Alicia Robles, Julian Gorrochategui, Jesus Sanchez, Joan Ballesteros, PhD, Federico Moscardo, MD, David Martinez, MD, Miguel Angel Sanz, MD, Jaime Pérez de Oteyza, MD, Joaquin Martinez, MD

Blood (2014) 124 (21): 5311.

https://doi.org/10.1182/blood.V124.21.5311.5311

Published: 2014

Journal Articles

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, Virginia Bosó, PharmD, Federico Moscardo, MD, María José Herrero, PhD, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, MD, Luis Rojas, Blanca Boluda, Jesus Martinez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, Carmen Alonso, MD, Aima Lacharro, José Cervera, José Luis Poveda, PhD, Salvador Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2014) 124 (21): 5223.

https://doi.org/10.1182/blood.V124.21.5223.5223

Published: 2014

Journal Articles

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Juan Eduardo Megías, PharmD, Pau Montesinos, MD, María José Herrero, PhD, Federico Moscardo, MD, Virginia Bosó, PharmD, David Martínez-Cuadrón, Luis Rojas, Rebeca Rodríguez-Veiga, MD, Blanca Boluda, Jesus Martinez, MD, Jaime Sanz, MD, Francisca López, MD, Isabel Cano, Carmen Alonso, MD, Aima Lacharro, José Cervera, José Luis Poveda, PhD, Salvador Aliño, PhD, Miguel Ángel Sanz, MD PhD

Blood (2014) 124 (21): 2237.

https://doi.org/10.1182/blood.V124.21.2237.2237

Published: 2014

Journal Articles

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Blood (2013) 122 (21): 3923.

https://doi.org/10.1182/blood.V122.21.3923.3923

Published: 2013

Journal Articles

Treatment With Leukapheresis In Patients Diagnosed With Hyperleukocytic Acute Myeloid Leukemia

David Martínez-Cuadrón, Pau Montesinos, Federico Moscardo, Lineth Lopez, MD, Guillermo Martin, Pilar Solves, Blanca Boluda, Mariluz Pérez-Sirvent, Belen Vera, Ines Navarro, Carmen M Alonso, Jesus Martinez, MD, Francisca López-Chulia, Jaime Sanz, MD, Nelly Carpio, Rebeca Rodríguez-Veiga, Gloria Iacoboni, Guillermo Sanz, MD, PhD, Miguel Sanz

Blood (2013) 122 (21): 5046.

https://doi.org/10.1182/blood.V122.21.5046.5046

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Blood (2013) 122 (21): 1347.

https://doi.org/10.1182/blood.V122.21.1347.1347

Published: 2013

Journal Articles

Clofarabine in Acute Myeloid Leukemia. the Spanish Experience

Blood (2011) 118 (21): 4279.

https://doi.org/10.1182/blood.V118.21.4279.4279

Published: 2011

Journal Articles

Quantitative Expression Analysis of WT1 Main Isoforms in AML

Irene Luna, MD, Esperanza Such, Jose Cervera, MD, Eva Barragan, PhD, Marta Llop, Mariam Ibañez, Inés Gómez-Seguí, MD., Beatriz Costan, Oscar Fuster, PhD, Sandra Dolz, Federico Moscardo, MD, Pau Montesinos, MD, Maria López-Pavia, MD, David Martinez-Cuadrón, MD, Silvestre Oltra, Pascual Bolufer, Miguel A. Sanz, MD, PhD

Blood (2011) 118 (21): 1469.

https://doi.org/10.1182/blood.V118.21.1469.1469

Published: 2011

Journal Articles

Analysis of ASXL1, IDH1, IDH2, c-CBL , and WT1 Mutations in De Novo Acute Myeloid Leukaemia

Mariam Ibañez, Esperanza Such, Jose Cervera, MD, Irene Luna, MD, Sandra Dolz, Inés Gómez-Seguí, MD., Maria López-Pavia, MD, Beatriz Costan, Eva Barragan, PhD, Oscar Fuster, PhD, Marta Llop, Silvestre Oltra, Federico Moscardo, MD, Pau Montesinos, MD, David Martinez-Cuadrón, MD, Miguel A. Sanz, MD, PhD

Blood (2011) 118 (21): 1450.

https://doi.org/10.1182/blood.V118.21.1450.1450

Published: 2011

Journal Articles

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Jaime Sanz, Pau Montesinos, David Martinez, Ignacio Lorenzo, Javier Palau, Luis Larrea, Dolores Planelles, Guillermo Martin, Isidro Jarque, Javier De La Rubia, Federico Moscardo, Jesus Martinez, Miguel Angel Sanz, Guillermo F Sanz, MD, PhD

Blood (2010) 116 (21): 1339.

https://doi.org/10.1182/blood.V116.21.1339.1339

Published: 2010

Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Blood (2009) 114 (22): 290.

https://doi.org/10.1182/blood.V114.22.290.290

Published: 2009

Journal Articles

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML)

Jai me Sanz, MD, Silvana Saavedra, MD, Pau Montesinos, MD, Ignacio Lorenzo, MD-PhD, Javier Palau, MDPhD, Luis Larrea, MD-PhD, Dolores Planelles, MD, Guillermo Martín, MD-PhD, Leonor Senent, MD, Isidro Jarque, MD-PhD, Javier de la Rubia, Federico Moscardo, MD, Jesus Martinez, MD-PhD, Shirley Weiss, Miguel A. Sanz, MD, PhD, Guillermo Sanz, MD, PhD

Blood (2008) 112 (11): 4401.

https://doi.org/10.1182/blood.V112.11.4401.4401

Published: 2008

Journal Articles

Efficacy and Safety of Rituximab in Adult Patients with Idiopathic Relapsed or Refractory Thrombotic Thrombocytopenic Purpura (TTP). Results of a Spanish Multicenter Study.

Javi er de la Rubia, Federico Moscardo, María J Gómez, Ramon Guardia, Pilar Rodriguez, Ana Sebrango, Concha Zamora, Guillermo Deben, Rosa Goterri, Rafaela Lopez, Francisco Peña, Micola Pujol

Blood (2008) 112 (11): 2289.

https://doi.org/10.1182/blood.V112.11.2289.2289

Published: 2008

Journal Articles

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).

Jaime Sanz, MD, Ignacio Lorenzo, MD-PHD, Pau Montesinos, MD, Leonor Senent, MD, Luis Larrea, MD-PHD, Dolores Planelles, MD, Guillermo Martin, MD-PHD, Jose Cervera, MD, Isidro Jarque, MD, Javier de la Rubia, MD, Guillermo Orti, MD, Miguel Scaff, MD, Mari Liz Paciello, MD, Federico Moscardo, MD, Monica Romero, MD, Luis Benlloch Biologist, Miguel A. Sanz, MD-PHD, Guillermo Sanz, MD-PHD

Blood (2007) 110 (11): 2024.

https://doi.org/10.1182/blood.V110.11.2024.2024

Published: 2007

NARROW

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Treatment With Leukapheresis In Patients Diagnosed With Hyperleukocytic Acute Myeloid Leukemia

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Clofarabine in Acute Myeloid Leukemia. the Spanish Experience

Quantitative Expression Analysis of WT1 Main Isoforms in AML

Analysis of ASXL1, IDH1, IDH2, c-CBL , and WT1 Mutations in De Novo Acute Myeloid Leukaemia

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML)

Efficacy and Safety of Rituximab in Adult Patients with Idiopathic Relapsed or Refractory Thrombotic Thrombocytopenic Purpura (TTP). Results of a Spanish Multicenter Study.

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only